Related Experiment Video
Updated: Jan 4, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Splice-variant-specific effects of primary aldosteronism point mutations on human CaV3.2 calcium channels
Min He1, Zilan Xu1, Yuchen Zhang1
1Department of Physiology and Biophysics, School of Life Sciences, Institutes of Brain Science, Fudan University, Shanghai, China.
Abstract:
CaV3.2 calcium channels play important roles in both neural excitability and aldosterone secretion. Recent clinical studies found four germline mutations (S196 L, M1549I, V1951E and P2083 L) in CaV3.2 channels. All four mutations caused primary aldosteronism (PA), while only the M1549I mutation resulted in obvious neural malfunctions besides PA. In human, there are two major CaV3.2 channel gene (CACNA1H) splice variants, either with or without exon 26. In this study, we tested the expression of the two CACNA1H splice variants in zona glomerulosa (ZG) cells of human adrenal cortex and the possibility that CaV3.2 (-26) and CaV3.2 (+26) channels have different functional responses to the four PA mutations. We found that human ZG cells only express long form CaV3.2(+26) channels. The M1549I mutation slowed the inactivation of CaV3.2(+26) more than 5 fold, and CaV3.2(-26) more than 2 fold. The S196 L, V1951E and P2083 L mutations accelerated channel recovery from inactivation for CaV3.2(+26), but not CaV3.2(-26) channels. All four mutations resulted in gain of function of CaV3.2(+26) channels, leading to overproduction of aldosterone. In conclusion, the four PA mutations caused more profound changes on CaV3.2 (+26) currents than on CaV3.2 (-26) currents, and except the M1549I mutation, the S196 L, V1951E and P2083 L have little effect on the electrophysiological properties of CaV3.2(-26) currents, which may partially explain the limitation of the phenotype associated with the V1951E, S196 L and P2083 L germline mutations to PA.
Insights
Four CACNA1H gene mutations cause primary aldosteronism by altering CaV3.2(+26) channel function. These mutations primarily impact the long splice variant, explaining their specific clinical effects.
Area of Science:
- Molecular biology
- Channelopathies
- Endocrinology
Background:
- CaV3.2 calcium channels are crucial for neural excitability and aldosterone secretion.
- Four germline mutations in CACNA1H (CaV3.2 channels) are linked to primary aldosteronism (PA).
- The M1549I mutation additionally causes neural malfunctions, suggesting variant-specific effects.
Purpose of the Study:
- To investigate the expression of CACNA1H splice variants in human adrenal zona glomerulosa (ZG) cells.
- To determine the functional consequences of four PA-associated mutations on CaV3.2(-26) and CaV3.2(+26) channel variants.
Main Methods:
- Analysis of CACNA1H splice variant expression in human ZG cells.
- Electrophysiological characterization of CaV3.2(-26) and CaV3.2(+26) channels with S196L, M1549I, V1951E, and P2083L mutations.
Main Results:
- Human ZG cells exclusively express the long CaV3.2(+26) splice variant.
- M1549I mutation significantly slowed CaV3.2(+26) inactivation ( >5-fold) and CaV3.2(-26) inactivation (>2-fold).
- S196L, V1951E, and P2083L mutations accelerated CaV3.2(+26) recovery from inactivation but not CaV3.2(-26).
- All four mutations induced a gain-of-function in CaV3.2(+26) channels, leading to aldosterone overproduction.
Conclusions:
- The four PA mutations exert more significant functional changes on CaV3.2(+26) than CaV3.2(-26) channels.
- The limited effect of S196L, V1951E, and P2083L mutations on CaV3.2(-26) electrophysiology may explain their phenotype restriction to PA.
More Related Videos
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antihypertensive Drugs: Potassium-Sparing Diuretics
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Mutations